vs
PDF SOLUTIONS INC（PDFS）与Xtant Medical Holdings, Inc.（XTNT）财务数据对比。点击上方公司名可切换其他公司
PDF SOLUTIONS INC的季度营收约是Xtant Medical Holdings, Inc.的1.9倍（$62.4M vs $32.4M），Xtant Medical Holdings, Inc.净利率更高（0.2% vs -0.1%，领先0.3%），PDF SOLUTIONS INC同比增速更快（24.6% vs 2.7%），PDF SOLUTIONS INC自由现金流更多（$7.5M vs $5.0M），过去两年PDF SOLUTIONS INC的营收复合增速更高（22.9% vs 7.7%）
PDF Solutions Inc是一家总部位于美国加利福尼亚州圣克拉拉的跨国企业，主营软件业务与工程技术服务，目前在纳斯达克交易所挂牌上市，股票代码为PDFS。
Xtant Medical Holdings是一家全球医疗技术企业，主营骨科生物制剂、神经外科器械及再生医学解决方案，为骨科与神经科诊疗机构提供脊柱手术耗材、骨再生产品等，服务覆盖北美、欧洲及亚太多个地区市场。
PDFS vs XTNT — 直观对比
营收规模更大
PDFS
是对方的1.9倍
$32.4M
营收增速更快
PDFS
高出21.9%
2.7%
净利率更高
XTNT
高出0.3%
-0.1%
自由现金流更多
PDFS
多$2.6M
$5.0M
两年增速更快
PDFS
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.4M | $32.4M |
| 净利润 | $-48.0K | $57.0K |
| 毛利率 | 72.9% | 54.9% |
| 营业利润率 | 5.5% | -2.9% |
| 净利率 | -0.1% | 0.2% |
| 营收同比 | 24.6% | 2.7% |
| 净利润同比 | -108.9% | 101.8% |
| 每股收益（稀释后） | $0.00 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PDFSXTNT
| Q4 25 | $62.4M | $32.4M | ||
| Q3 25 | $57.1M | $33.3M | ||
| Q2 25 | $51.7M | $35.4M | ||
| Q1 25 | $47.8M | $32.9M | ||
| Q4 24 | $50.1M | $31.5M | ||
| Q3 24 | $46.4M | $27.9M | ||
| Q2 24 | $41.7M | $29.9M | ||
| Q1 24 | $41.3M | $27.9M |
净利润PDFSXTNT
| Q4 25 | $-48.0K | $57.0K | ||
| Q3 25 | $1.3M | $1.3M | ||
| Q2 25 | $1.1M | $3.5M | ||
| Q1 25 | $-3.0M | $58.0K | ||
| Q4 24 | $539.0K | $-3.2M | ||
| Q3 24 | $2.2M | $-5.0M | ||
| Q2 24 | $1.7M | $-3.9M | ||
| Q1 24 | $-393.0K | $-4.4M |
毛利率PDFSXTNT
| Q4 25 | 72.9% | 54.9% | ||
| Q3 25 | 72.3% | 66.1% | ||
| Q2 25 | 71.2% | 68.6% | ||
| Q1 25 | 72.9% | 61.5% | ||
| Q4 24 | 68.3% | 50.9% | ||
| Q3 24 | 73.1% | 58.4% | ||
| Q2 24 | 70.6% | 62.1% | ||
| Q1 24 | 67.3% | 62.1% |
营业利润率PDFSXTNT
| Q4 25 | 5.5% | -2.9% | ||
| Q3 25 | 8.5% | 7.6% | ||
| Q2 25 | 2.2% | 13.1% | ||
| Q1 25 | -7.4% | 3.2% | ||
| Q4 24 | 1.0% | -6.0% | ||
| Q3 24 | 4.6% | -13.5% | ||
| Q2 24 | 0.6% | -9.8% | ||
| Q1 24 | -4.7% | -12.4% |
净利率PDFSXTNT
| Q4 25 | -0.1% | 0.2% | ||
| Q3 25 | 2.3% | 3.9% | ||
| Q2 25 | 2.2% | 10.0% | ||
| Q1 25 | -6.3% | 0.2% | ||
| Q4 24 | 1.1% | -10.0% | ||
| Q3 24 | 4.8% | -18.0% | ||
| Q2 24 | 4.1% | -12.9% | ||
| Q1 24 | -1.0% | -15.8% |
每股收益（稀释后）PDFSXTNT
| Q4 25 | $0.00 | $0.00 | ||
| Q3 25 | $0.03 | $0.01 | ||
| Q2 25 | $0.03 | $0.02 | ||
| Q1 25 | $-0.08 | $0.00 | ||
| Q4 24 | $0.01 | $-0.02 | ||
| Q3 24 | $0.06 | $-0.04 | ||
| Q2 24 | $0.04 | $-0.03 | ||
| Q1 24 | $-0.01 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.2M | $17.1M |
| 总债务越低越好 | $67.0M | $11.0M |
| 股东权益账面价值 | $271.0M | $51.0M |
| 总资产 | $418.7M | $94.1M |
| 负债/权益比越低杠杆越低 | 0.25× | 0.22× |
8季度趋势，按日历期对齐
现金及短期投资PDFSXTNT
| Q4 25 | $42.2M | $17.1M | ||
| Q3 25 | $35.9M | $10.4M | ||
| Q2 25 | $40.4M | $6.9M | ||
| Q1 25 | $54.1M | $5.0M | ||
| Q4 24 | $114.9M | $6.2M | ||
| Q3 24 | $120.2M | $6.6M | ||
| Q2 24 | $117.9M | $5.4M | ||
| Q1 24 | $122.9M | $4.5M |
总债务PDFSXTNT
| Q4 25 | $67.0M | $11.0M | ||
| Q3 25 | $67.6M | $17.4M | ||
| Q2 25 | $68.1M | $22.3M | ||
| Q1 25 | $68.7M | $22.2M | ||
| Q4 24 | — | $22.0M | ||
| Q3 24 | — | $19.1M | ||
| Q2 24 | — | $21.8M | ||
| Q1 24 | — | $16.8M |
股东权益PDFSXTNT
| Q4 25 | $271.0M | $51.0M | ||
| Q3 25 | $264.4M | $50.4M | ||
| Q2 25 | $257.5M | $48.5M | ||
| Q1 25 | $249.0M | $43.9M | ||
| Q4 24 | $246.0M | $43.0M | ||
| Q3 24 | $240.5M | $45.7M | ||
| Q2 24 | $232.2M | $45.0M | ||
| Q1 24 | $225.4M | $47.7M |
总资产PDFSXTNT
| Q4 25 | $418.7M | $94.1M | ||
| Q3 25 | $406.4M | $106.3M | ||
| Q2 25 | $391.1M | $103.5M | ||
| Q1 25 | $390.0M | $95.8M | ||
| Q4 24 | $315.3M | $93.8M | ||
| Q3 24 | $307.4M | $98.9M | ||
| Q2 24 | $298.0M | $95.6M | ||
| Q1 24 | $286.8M | $93.9M |
负债/权益比PDFSXTNT
| Q4 25 | 0.25× | 0.22× | ||
| Q3 25 | 0.26× | 0.35× | ||
| Q2 25 | 0.26× | 0.46× | ||
| Q1 25 | 0.28× | 0.51× | ||
| Q4 24 | — | 0.51× | ||
| Q3 24 | — | 0.42× | ||
| Q2 24 | — | 0.48× | ||
| Q1 24 | — | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.3M | $5.4M |
| 自由现金流经营现金流 - 资本支出 | $7.5M | $5.0M |
| 自由现金流率自由现金流/营收 | 12.1% | 15.4% |
| 资本支出强度资本支出/营收 | 15.7% | 1.2% |
| 现金转化率经营现金流/净利润 | — | 94.39× |
| 过去12个月自由现金流最近4个季度 | $-8.6M | $10.2M |
8季度趋势，按日历期对齐
经营现金流PDFSXTNT
| Q4 25 | $17.3M | $5.4M | ||
| Q3 25 | $3.3M | $4.6M | ||
| Q2 25 | $-5.2M | $1.3M | ||
| Q1 25 | $8.6M | $1.3M | ||
| Q4 24 | $1.6M | $665.0K | ||
| Q3 24 | $9.3M | $-1.7M | ||
| Q2 24 | $684.0K | $-5.1M | ||
| Q1 24 | $-1.9M | $-5.8M |
自由现金流PDFSXTNT
| Q4 25 | $7.5M | $5.0M | ||
| Q3 25 | $-2.9M | $4.2M | ||
| Q2 25 | $-13.8M | $910.0K | ||
| Q1 25 | $535.0K | $87.0K | ||
| Q4 24 | $-4.0M | $-7.0K | ||
| Q3 24 | $5.1M | $-3.8M | ||
| Q2 24 | $-4.6M | $-5.7M | ||
| Q1 24 | $-3.9M | $-6.5M |
自由现金流率PDFSXTNT
| Q4 25 | 12.1% | 15.4% | ||
| Q3 25 | -5.1% | 12.6% | ||
| Q2 25 | -26.6% | 2.6% | ||
| Q1 25 | 1.1% | 0.3% | ||
| Q4 24 | -8.0% | -0.0% | ||
| Q3 24 | 11.0% | -13.7% | ||
| Q2 24 | -11.1% | -18.9% | ||
| Q1 24 | -9.4% | -23.4% |
资本支出强度PDFSXTNT
| Q4 25 | 15.7% | 1.2% | ||
| Q3 25 | 10.8% | 1.3% | ||
| Q2 25 | 16.5% | 1.0% | ||
| Q1 25 | 17.0% | 3.6% | ||
| Q4 24 | 11.3% | 2.1% | ||
| Q3 24 | 9.0% | 7.5% | ||
| Q2 24 | 12.8% | 1.9% | ||
| Q1 24 | 4.9% | 2.8% |
现金转化率PDFSXTNT
| Q4 25 | — | 94.39× | ||
| Q3 25 | 2.54× | 3.53× | ||
| Q2 25 | -4.55× | 0.36× | ||
| Q1 25 | — | 22.03× | ||
| Q4 24 | 2.98× | — | ||
| Q3 24 | 4.20× | — | ||
| Q2 24 | 0.40× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PDFS
| Volumebased | $38.0M | 61% |
| Other | $24.4M | 39% |
XTNT
| Orthobiologics | $18.3M | 57% |
| Spinal Implant | $9.4M | 29% |
| License Revenue | $4.6M | 14% |
